Clinical Development Clinical Supply Pharmaceuticals 
The Pharma Data
SEPTEMBER 15, 2020
Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.
The Pharma Data
JANUARY 24, 2021
Management of the Company believe that the proposed acquisition will strengthen PharmaDrug’s product pipeline, intellectual property portfolio and pharmaceutical development expertise. Sairiyo is currently focused on advancing the clinical development of Cepharanthine to treat rare cancer diseases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
OCTOBER 27, 2020
Under the agreement, during the option period, Molecular Partners will conduct Phase 1 clinical trials for MP0420, expected to begin in November 2020, and perform all remaining preclinical work for MP0423 and Novartis will conduct Phase 2 and Phase 3 clinical trials, with Molecular Partners as sponsor of these trials.
BioPharma Drive: Drug Pricing
JUNE 9, 2025
Also, we should not rely solely on pharmaceuticals to address the root causes of systemic health issues. These drugs could drastically lower rates of many life-affecting diseases and ailments, such as diabetes, cardiovascular disease and other metabolic disorders and contribute to improving millions of lives.
BioPharma Drive: Drug Pricing
JUNE 9, 2025
But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.
BioPharma Drive: Drug Pricing
JUNE 5, 2025
“I find it very exciting as well as surprising that the FDA is putting their foot on the gas in terms of helping roll out AI internally within the agency, because it actually aligns quite nicely with the adoption speed that were seeing within the pharmaceutical manufacturing side of the table,” Feiger said.
Drug Target Review
MAY 27, 2025
I worked to continually grow my expertise, responsibility, and leadership before ultimately taking on my current role as Senior Vice President and Global Head of Clinical Operations at BeOne. My proudest achievement is my leadership journey building legacy organisations, processes and tools in clinical operations.
Expert insights. Personalized for you.
Let's personalize your content